Nrf2 protects stellate cells from Smad-dependent cell activation.
Hepatic stellate cells (HSC) orchestrate the deposition of extracellular matrix (ECM) and are the primary effector of liver fibrosis. Several factors, including TGF-β1, PDGF and oxidative stress, have been shown to trigger HSC activation. However, the involvement of cellular defence mechanisms, such...
Main Authors: | Vincenzo Prestigiacomo, Laura Suter-Dick |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6054401?pdf=render |
Similar Items
-
Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
by: Vincenzo Prestigiacomo, et al.
Published: (2017-01-01) -
MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7
by: Li-Ying Song, et al.
Published: (2017-01-01) -
Curcumin downregulates Smad pathways and reduces hepatic stellate cells activation in experimental fibrosis
by: Erika Hernández-Aquino, et al.
Published: (2020-09-01) -
Xiaochaihutang Inhibits the Activation of Hepatic Stellate Cell Line T6 Through the Nrf2 Pathway
by: Rui Hu, et al.
Published: (2019-01-01) -
SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate CellsSummary
by: Xiaolin Zhong, et al.
Published: (2020-01-01)